How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Related NICE guidance

    Below is a list of NICE guidance related to this procedure.

    Interventional procedures

    Technology appraisals

    • Rivaroxaban for preventing major cardiovascular events in people with coronary or peripheral artery disease. NICE technology appraisal 607 (2019). Available from www.nice.org.uk/guidance/TA607

    • Drug-eluting stents for the treatment of coronary artery disease. NICE technology appraisal 152 (2008). Available from: www.nice.org.uk/guidance/TA152

    • Guidance on the use of coronary artery stents. NICE technology appraisal 71 (2003). Available from www.nice.org.uk/guidance/TA71

    Medical technologies

    • HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. NICE medical technologies guidance 32 (2017, updated 2021). Available from:

    • http://guidance.nice.org.uk/MTG32

    • MiraQ for assessing graft flow during coronary artery bypass graft surgery. NICE medical technology guidance 8 (2011) Available from:

    • http://guidance.nice.org.uk/MTG8

    • SeQuent Please balloon catheter for in-stent coronary restenosis. NICE medical technology guidance 1 (2010). Available from:

    • http://guidance.nice.org.uk/MTG1

    NICE guidelines